Aakaar Medical Technologies logo

Aakaar Medical Technologies financials and balance sheet

NSE: AAKAARPersonal Products

Last close ₹63.80down ₹3.35 (4.99%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹67.15.

52-week range of traded prices to 23 Oct 2026
₹46.00Low, 27 Mar 2026₹90.00High, 24 Oct 2025
Market cap
₹90 Cr
P/E
13.6
P/B
1.7
Dividend yield
Nonein the last 12 months
ROE
12.2%
Debt to equity
0.34
Volume, NSE
3,200100.0% delivered

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Aakaar Medical Technologies annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue67
  2. Materials and goods−28
  3. Employee costs−14
  4. Other expenses−14
  5. Operating profit10
  6. Depreciation−0.1
  7. Other income+0.8
  8. Finance costs−1.8
  9. Profit before tax9.2
  10. Tax−2.6
  11. Net profit6.6

What the company owns

  • Receivables₹37 Cr
  • Inventory₹20 Cr
  • Cash and bank₹16 Cr
  • Plant, investments and other assets₹6 Cr

What pays for it: net worth and liabilities

  • Net worth₹55 Cr
  • Borrowings₹19 Cr
  • Other liabilities₹4 Cr
  • Owed to suppliers₹2 Cr

Aakaar Medical Technologies business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them.Aakaar Medical Technologies segment results by half year

Revenue by segment

₹67 CrTotal
  • Aesthetic Products₹59.6 Cr89.0% of total
  • Aesthetic Devices & Device Consumables₹7.4 Cr11.0% of total

Profit by segment

  • Aesthetic Products₹35.8 Cr92.3% of total
  • Aesthetic Devices & Device Consumables₹3.0 Cr7.7% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Aesthetic Products

    Revenue, ₹ crore
    Profit, ₹ crore
  • Aesthetic Devices & Device Consumables

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2026
Revenue of all businesses67.0
Company revenue, as in its results67.0
Revenue59.6
Profit35.8
Margin60.0%
Assets46.6
Revenue7.4
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March.Aakaar Medical Technologies half-yearly results

₹ croreMar 2026Filed 17 Jun
Revenue from operations67.0
56.7
Materials and goods bought28.2
Employee costs14.0
Other expenses14.4
Operating profit before depreciation10.3
Operating margin15.4%
Materials, % of revenue42.1%
Employee costs, % of revenue20.9%
Other expenses, % of revenue21.6%
Depreciation and amortisation0.1
Operating profit after depreciation10.2
Other income0.8
Finance costs1.8
Profit before tax9.2
2.6
Net profit6.6
Net margin9.9%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2026Filed 17 Jun
54.6
Share capital14.2
Reserves40.4
Borrowings18.5
23.9
Liabilities due after a year1.0
Total assets79.4
2.8
76.6
Net debt2.3
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2026Filed 17 Jun
−8.4
−5.3
−16.6
Receivables−9.5
Inventories−5.2
Payables−1.6
Other working capital−0.3
Tax paid−2.3
Capital spending0.6
Free cash flow−8.9
0.0
18.8
Dividends paid0.0
Shares issued27.0
Net change in cash10.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2026Filed 17 Jun
Earnings per share₹4.99
Diluted earnings per share₹4.99
Book value per share₹38.49
Shareholder yield−39.6%
Market cap at the year end (₹ crore)68.2
RatioMar 2026Filed 17 Jun
Return on equity12.2%
Return on capital employed13.9%
Cash conversion−126.0%
Interest cover5.7
Debt to equity0.34
Receivable days203
Inventory days256
Payable days24
Cash conversion cycle, days434
Working capital days300
Asset turnover0.84
Assets per rupee of net worth1.46
Sales per rupee of plant395.30
Capital spending to depreciation4.51

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
8.4%
Cash from operations against operating profit
−81.1%

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−8.4
Cash from investing0.0
Cash from financing18.8
Capital spending0.6
Dividends paid0.0
Shares issued for cash27.0
Borrowings raised0.0
Borrowings repaid2.5

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent27.79
Tax charged less tax paid, % of profitOur threshold 10 percentage points3.31
A threshold marked as ours has no published figure; it is the line we read the check against.